Heart Disease Clinical Trials in Austin

Showing 261-280 of 301 trials

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

NCT01229137

Assessment of sensor parameter in patients with heart failure.

Boston Scientific Corporation71 participantsStarted Jun 2011

Jonesboro, Arkansas, United States • Sacremento, California, United States • Danbury, Connecticut, United States +11 more locations

COMPLETED< 1 mile

Attain Success Clinical Trial

NCT00990964

The purpose of the study is to assess lead implant success and complication rate using the Medtronic Attain Family of left-heart leads and delivery catheters.

Heart Failure

Medtronic Cardiac Rhythm and Heart Failure2,014 participantsStarted Nov 2009

Little Rock, Arkansas, United States • Downey, California, United States • Modesto, California, United States +105 more locations

Physiological Response to Exercise: Sensor Evaluation at Specified Exertions

Attain Success Clinical Trial

Heart Disease Trials in Other Cities

REsynchronization reVErses Remodeling in Systolic Left vEntricular Dysfunction (REVERSE)

SPIRIT III Clinical Trial of the XIENCE V® Everolimus Eluting Coronary Stent System (EECSS)

TAXUS ATLAS: TAXUS Liberté™-SR Stent for the Treatment of de Novo Coronary Artery Lesions

Study of the Safety and Efficacy of Apadenoson for Detection of Myocardial Perfusion Defects Using SPECT MPI

Assessing the Safety/Efficacy of Transdermal Testosterone in Female Patients With Symptomatic Heart Failure

SYNTAX Study: TAXUS Drug-Eluting Stent Versus Coronary Artery Bypass Surgery for the Treatment of Narrowed Arteries

Paracor Ventricular Support System (PVSS) for Patients With Heart Failure

A Study of the Safety and Tolerance of Regadenoson in Subjects With Renal Impairment

Heart Pressure Assessment Study With Tolvaptan to Treat Congestive Heart Failure

A Study of the Onset and Offset of Antiplatelet Effects Comparing Ticagrelor, Clopidogrel, and Placebo With Aspirin

Study to Assess the Safety and Efficacy of CD-NP in the Treatment of Patients With Acute Decompensated Heart Failure

SPIRIT IV Clinical Trial: Clinical Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System

Reducing Decompensation Events Utilizing Intracardiac Pressures in Patients With Chronic Heart Failure (HF) (REDUCEhf)

The WOMEN Study: What is the Optimal Method for Ischemia Evaluation in WomeN?

The Effect of Nebivolol in Hypertensive Patients With Coronary Artery Disease

Direct Stenting of TAXUS Liberté™-SR Stent for the Treatment of Patients With de Novo Coronary Artery Lesions

Safety and Efficacy Study of KAI-9803 to Treat Subjects With ST Elevation Myocardial Infarction [Heart Attack]

SPIRIT V: Post-marketing Evaluation of the XIENCE V® Everolimus Eluting Coronary Stent System in Europe

Other Conditions in Austin